{
    "code": 0,
    "data": [
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Please find attached herewith the Transcript of Post Result Conference Call held on 05th February 2026.",
            "news_id": "7bc0b385-e18a-4657-9587-88362212657b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7eca3970-89d2-42e5-ba67-8ab7bc7e1dc9.pdf",
            "news_date": "2026-02-11 19:11:07",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 40294,
            "bse_code": 533573,
            "isin": "INE901L01018",
            "ann_type": "General_Announcements",
            "descriptor": "Earnings Call Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Please find attached herewith the Transcript of Post Result Conference Call held on 05th February 2026.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7eca3970-89d2-42e5-ba67-8ab7bc7e1dc9.pdf",
            "news_date": "2026-02-11 19:11:07"
        },
        {
            "co_code": 40294,
            "bse_code": 533573,
            "isin": "INE901L01018",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Please find attached Newspaper Publication",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0ff84518-ab68-489f-a3b1-d85c2e2b88ec.pdf",
            "news_date": "2026-02-11 17:11:00"
        },
        {
            "co_code": 40294,
            "bse_code": 533573,
            "isin": "INE901L01018",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper Publication of Unaudited Financials Results for the Quarter and Nine Months Ended 31st December 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4005dcf0-c866-4bf5-bbdc-a28bd05aad63.pdf",
            "news_date": "2026-02-06 15:20:11"
        },
        {
            "co_code": 40294,
            "bse_code": 533573,
            "isin": "INE901L01018",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Alembic Pharmaceuticals Limited receives USFDA Final Approval for Carbidopa Levodopa and Entacapone Tablets",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=20dac301-2654-42d1-9e0f-1599f453ab69.pdf",
            "news_date": "2026-02-06 11:31:45"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Submission of Audio Recording of Post Results Conference Call held on 5th February 2026",
            "news_id": "505595c3-20e7-4af7-90b3-23ac55ed5934",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8cc9e401-65c8-4f78-9667-24920ae9e549.pdf",
            "news_date": "2026-02-05 19:26:13",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 40294,
            "bse_code": 533573,
            "isin": "INE901L01018",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Submission of Audio Recording of Post Results Conference Call held on 5th February 2026",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8cc9e401-65c8-4f78-9667-24920ae9e549.pdf",
            "news_date": "2026-02-05 19:26:13"
        },
        {
            "co_code": 40294,
            "bse_code": 533573,
            "isin": "INE901L01018",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Directorate",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Directorate",
            "news_body": "Please find attached the intimation of appointment of Mr. Raj Kumar Baheti (DIN:00332079) as Non-Executive Non Independent Director of the Company.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=804f574a-a336-447a-a7c7-4876088e7a31.pdf",
            "news_date": "2026-02-05 16:15:16"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find attached herewith the Revised Investor Presentation",
            "news_id": "93c714a5-4b15-4514-ad80-341b85e452fe",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=46c93f24-1700-455c-b9cd-ab997c99dfbc.pdf",
            "news_date": "2026-02-05 15:12:52",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 40294,
            "bse_code": 533573,
            "isin": "INE901L01018",
            "ann_type": "General_Announcements",
            "descriptor": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find attached herewith the Revised Investor Presentation",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=46c93f24-1700-455c-b9cd-ab997c99dfbc.pdf",
            "news_date": "2026-02-05 15:12:52"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For Quarter And Nine Months Ended 31St December 2025",
            "news_body": "Unaudited financial results for the quarter and nine months ended 31st  December 2025",
            "news_id": "a258be3d-cbdc-4091-ba75-49d084c00301",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4e184f18-4280-4bd6-9651-fc572826dbde.pdf",
            "news_date": "2026-02-05 14:22:47",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 40294,
            "bse_code": 533573,
            "isin": "INE901L01018",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Unaudited Financial Results For Quarter And Nine Months Ended 31St December 2025",
            "news_body": "Unaudited financial results for the quarter and nine months ended 31st  December 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4e184f18-4280-4bd6-9651-fc572826dbde.pdf",
            "news_date": "2026-02-05 14:22:47"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find attached the investor presentation",
            "news_id": "ab43ca2d-7ec4-42b1-b6a7-5197060cb126",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d92917fa-fbdb-465c-bab7-1d2b1baaccf1.pdf",
            "news_date": "2026-02-05 14:16:29",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 40294,
            "bse_code": 533573,
            "isin": "INE901L01018",
            "ann_type": "General_Announcements",
            "descriptor": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find attached the investor presentation",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d92917fa-fbdb-465c-bab7-1d2b1baaccf1.pdf",
            "news_date": "2026-02-05 14:16:29"
        },
        {
            "co_code": 40294,
            "bse_code": 533573,
            "isin": "INE901L01018",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "PFA the press release",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c900469a-8bf4-4a62-ab8e-2c9cb9b02b30.pdf",
            "news_date": "2026-02-05 14:13:59"
        },
        {
            "co_code": 40294,
            "bse_code": 533573,
            "isin": "INE901L01018",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting",
            "news_body": "Please find attached Unaudited Financial Results for the quarter and nine months ended 31st December 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e9b81fda-ca95-4f11-b995-ac2fa9dc4635.pdf",
            "news_date": "2026-02-05 14:00:03"
        },
        {
            "co_code": 40294,
            "bse_code": 533573,
            "isin": "INE901L01018",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Please find attached herewith Newspaper Publication related to Loss of Share Certificate",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ebd1d9c3-9f6e-48a7-b9c4-905a700e76c3.pdf",
            "news_date": "2026-02-03 14:47:14"
        },
        {
            "co_code": 40294,
            "bse_code": 533573,
            "isin": "INE901L01018",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Management",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
            "news_body": "Change in Senior Managerial Personnel",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=caf676fe-320f-40eb-b8cb-abd255620a63.pdf",
            "news_date": "2026-01-31 19:08:37"
        },
        {
            "co_code": 40294,
            "bse_code": 533573,
            "isin": "INE901L01018",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Alembic Pharmaceuticals Limited receives USFDA Final Approval for Difluprednate Ophthalmic Emulsion 0.05%.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d14112e6-9a83-4e12-ae2c-b1ef63bd7f6d.pdf",
            "news_date": "2026-01-27 12:36:59"
        },
        {
            "co_code": 40294,
            "bse_code": 533573,
            "isin": "INE901L01018",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Please find attached herewith the Intimation for Investors Call scheduled to be held on 5th February 2026.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=efb022fa-463c-4bb4-b9ee-74721cb6c3cf.pdf",
            "news_date": "2026-01-21 13:02:11"
        },
        {
            "co_code": 40294,
            "bse_code": 533573,
            "isin": "INE901L01018",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Unaudited Financial Results For The Quarter And Nine Months Ended 31St December 2025",
            "news_body": "Alembic Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/02/2026 inter alia to consider and approve Unaudited Financial Results for the quarter and nine months ended 31st December 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=228755d2-cfd3-4d21-a72c-f8e8dd9194bf.pdf",
            "news_date": "2026-01-20 10:28:56"
        },
        {
            "co_code": 40294,
            "bse_code": 533573,
            "isin": "INE901L01018",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Alembic Pharmaceuticals Limited announces USFDA Tentative approval for Bosutinib Tablets 400 mg.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1fecbbb6-e69a-4be6-a9a8-bf69bd0371f2.pdf",
            "news_date": "2026-01-12 12:07:54"
        },
        {
            "co_code": 40294,
            "bse_code": 533573,
            "isin": "INE901L01018",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Please find attached herewith the Certificate under Regulation 74(5) of SEBI (DP) Regulations 2018 for the quarter ended 31st December 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3c9c6a29-e485-49d8-8cb4-8cbe40311acd.pdf",
            "news_date": "2026-01-05 17:04:27"
        },
        {
            "co_code": 40294,
            "bse_code": 533573,
            "isin": "INE901L01018",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Intimation of Closure of Trading Window.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=71ddccdd-2e77-4fa7-8218-444da2f9d1eb.pdf",
            "news_date": "2025-12-26 12:20:05"
        },
        {
            "co_code": 40294,
            "bse_code": 533573,
            "isin": "INE901L01018",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Alembic Pharmaceuticals Limited announces USFDA approval for Travoprost Ophthalmic Solutions",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=24ce4d25-de6d-4560-be40-da995aae872d.pdf",
            "news_date": "2025-12-18 11:00:18"
        },
        {
            "co_code": 40294,
            "bse_code": 533573,
            "isin": "INE901L01018",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Announcement Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015",
            "news_body": "Please find attached herewith announcement under Regulation 30 of SEBI (LODR) Regulations 2015",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=93c325a8-fc97-4142-8c82-1b3138dfe8ad.pdf",
            "news_date": "2025-12-16 16:03:06"
        },
        {
            "co_code": 40294,
            "bse_code": 533573,
            "isin": "INE901L01018",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Please find attached Newspaper Publication of Special Window for re-lodgement of transfer of physical shares.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=efb41bd1-243f-4b07-979c-dd86830aefa9.pdf",
            "news_date": "2025-12-15 16:37:23"
        },
        {
            "co_code": 40294,
            "bse_code": 533573,
            "isin": "INE901L01018",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Please find attached herewith a copy of advertisement elated to notice of loss of equity share certificate published by Company.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=972d58ab-5ea8-422c-971f-87a7f5462066.pdf",
            "news_date": "2025-12-12 18:47:34"
        },
        {
            "co_code": 40294,
            "bse_code": 533573,
            "isin": "INE901L01018",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Alembic Pharmaceuticals Limited receives USFDA Approval for Loteprednol Etabonate and Tobramycin Ophthalmic Suspension 0.5%/0.3%",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e32cf20d-a519-40db-8cec-a1e636575591.pdf",
            "news_date": "2025-12-11 11:53:48"
        },
        {
            "co_code": 40294,
            "bse_code": 533573,
            "isin": "INE901L01018",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Please find attached herewith a copy of advertisement related to notice of loss of equity share certificate.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=74167cf0-c72d-4b09-a6f0-249773ea1971.pdf",
            "news_date": "2025-12-09 18:48:54"
        },
        {
            "co_code": 40294,
            "bse_code": 533573,
            "isin": "INE901L01018",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "One on One meeting with ICICI Prudential Pharma Fund",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8aaea379-fea4-4600-9a7f-df4aa3f0a778.pdf",
            "news_date": "2025-12-04 22:56:26"
        },
        {
            "co_code": 40294,
            "bse_code": 533573,
            "isin": "INE901L01018",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Intimation of One on One Investor Meet",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b9386f98-9118-4e40-8555-75ff38e05287.pdf",
            "news_date": "2025-12-04 16:28:02"
        },
        {
            "co_code": 40294,
            "bse_code": 533573,
            "isin": "INE901L01018",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Management",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
            "news_body": "Resignation of Senior Managerial Personnel",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=15c75151-2a52-42a4-88b9-370c9744f04d.pdf",
            "news_date": "2025-12-01 18:41:53"
        },
        {
            "co_code": 40294,
            "bse_code": 533573,
            "isin": "INE901L01018",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Alembic Pharmaceuticals Limited announces USFDA Final Approval for Diltiazem Hydrochloride Tablets USP 30 mg 60 mg 90 mg and 120 mg",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=554d7812-a393-4070-8802-4227bf502a6c.pdf",
            "news_date": "2025-11-15 09:15:32"
        },
        {
            "co_code": 40294,
            "bse_code": 533573,
            "isin": "INE901L01018",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Alembic Pharmaceuticals Limited receives USFDA Final Approval for Dexlansoprazole Delayed-Release Capsules 30mg and 60 mg.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=19d7fed4-5149-45b8-90e7-cbb2b7639704.pdf",
            "news_date": "2025-11-13 11:45:03"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Please find attached herewith the Transcript of Post Result Conference Call held on 04th November 2025",
            "news_id": "61f14f21-bc45-4a50-94c3-868bef22417e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6924be80-9862-464e-a101-818e32429b4a.pdf",
            "news_date": "2025-11-11 12:07:29",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 40294,
            "bse_code": 533573,
            "isin": "INE901L01018",
            "ann_type": "General_Announcements",
            "descriptor": "Earnings Call Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Please find attached herewith the Transcript of Post Result Conference Call held on 04th November 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6924be80-9862-464e-a101-818e32429b4a.pdf",
            "news_date": "2025-11-11 12:07:29"
        },
        {
            "co_code": 40294,
            "bse_code": 533573,
            "isin": "INE901L01018",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Newspaper Publication",
            "news_body": "Please find attached herewith intimation regarding copy of newspaper advertisement related to notice of claiming shares from Companys Unclaimed Suspense Account.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5c20fedd-3665-46d5-b14f-dd1c0be3a5fb.pdf",
            "news_date": "2025-11-10 18:28:12"
        },
        {
            "co_code": 40294,
            "bse_code": 533573,
            "isin": "INE901L01018",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Alembic Pharmaceuticals Limited receives USFDA Final Approval for Sumatriptan Injection USP 4 mg/0.5 mL and 6 mg/0.5 mL Single-Dose Autoinjector System.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4ee2c0ad-0e36-4064-80e6-da7e6c768c36.pdf",
            "news_date": "2025-11-07 15:05:40"
        },
        {
            "co_code": 40294,
            "bse_code": 533573,
            "isin": "INE901L01018",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Alembic Pharmaceuticals Limited receives USFDA Final Approval for Dasatinib Tablets 20 mg 50 mg 70 mg 80 mg 100 mg and 140 mg.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=25010b14-8366-41ec-8588-85b3e4603221.pdf",
            "news_date": "2025-11-07 12:35:41"
        },
        {
            "co_code": 40294,
            "bse_code": 533573,
            "isin": "INE901L01018",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015",
            "news_body": "Please find attached herewith Intimation regarding Regulation 30",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=24f5ed5c-a6a1-46d8-9ea8-70cd83c19111.pdf",
            "news_date": "2025-11-06 21:56:05"
        },
        {
            "co_code": 40294,
            "bse_code": 533573,
            "isin": "INE901L01018",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper Publication of Unaudited Financial Results for the Quarter and Half Year Ended 30th September 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7a8f79dc-7ff8-4674-83eb-68c4ecf03fc1.pdf",
            "news_date": "2025-11-05 14:34:19"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Submission of Audio Recording of Post Results Conference Call held on 4th November 2025",
            "news_id": "b75563df-9484-48d0-9861-6d2d491c6284",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=aa23abbc-df33-4317-ade0-afa39e00919b.pdf",
            "news_date": "2025-11-04 18:01:09",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 40294,
            "bse_code": 533573,
            "isin": "INE901L01018",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Submission of Audio Recording of Post Results Conference Call held on 4th November 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=aa23abbc-df33-4317-ade0-afa39e00919b.pdf",
            "news_date": "2025-11-04 18:01:09"
        },
        {
            "co_code": 40294,
            "bse_code": 533573,
            "isin": "INE901L01018",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release (Revised)",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release (Revised)",
            "news_body": "Revised Press Release on the Unaudited Financial Results for the quarter and half year ended 30th September 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8d68e553-c474-455b-afb0-58e101a9ec75.pdf",
            "news_date": "2025-11-04 15:23:11"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation on Unaudited Financial Results of the Company for the quarter and half year ended 30th September 2025",
            "news_id": "b33111a0-2678-460f-b1df-d9d6670520ca",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7517e5c0-3e56-45fc-acd9-d392c6e0f2a9.pdf",
            "news_date": "2025-11-04 14:47:49",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 40294,
            "bse_code": 533573,
            "isin": "INE901L01018",
            "ann_type": "General_Announcements",
            "descriptor": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation on Unaudited Financial Results of the Company for the quarter and half year ended 30th September 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7517e5c0-3e56-45fc-acd9-d392c6e0f2a9.pdf",
            "news_date": "2025-11-04 14:47:49"
        },
        {
            "co_code": 40294,
            "bse_code": 533573,
            "isin": "INE901L01018",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Press Release on the Unaudited Financial Results for the quarter and half year ended 30th September 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f5507f18-df9b-4fde-8ad4-1af948089a4f.pdf",
            "news_date": "2025-11-04 14:43:14"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter And Half Year Ended 30Th September 2025. ",
            "news_body": "Please find attached unaudited financial results for the quarter and half year ended 30th September 2025",
            "news_id": "607f1158-66ed-42e8-b220-bd09b35d3a32",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=61b69ed5-405a-4863-8aa0-4e2b2b983e92.pdf",
            "news_date": "2025-11-04 14:39:09",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 40294,
            "bse_code": 533573,
            "isin": "INE901L01018",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter And Half Year Ended 30Th September 2025. ",
            "news_body": "Please find attached unaudited financial results for the quarter and half year ended 30th September 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=61b69ed5-405a-4863-8aa0-4e2b2b983e92.pdf",
            "news_date": "2025-11-04 14:39:09"
        },
        {
            "co_code": 40294,
            "bse_code": 533573,
            "isin": "INE901L01018",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Unaudited Financial Results For The Quarter And Half Year Ended 30Th September 2025",
            "news_body": "Unaudited Financial Results For The Quarter and Half Year Ended 30Th September 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e835dbc8-6767-42e7-8a08-ed4d16f22712.pdf",
            "news_date": "2025-11-04 14:28:57"
        },
        {
            "co_code": 40294,
            "bse_code": 533573,
            "isin": "INE901L01018",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Alembic Pharmaceuticals Limited announces USFDA Final Approval for Ticagrelor Tablets 60 mg",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d9c18eed-3b0a-492e-88e2-0d81c15dc6d7.pdf",
            "news_date": "2025-10-29 11:58:24"
        },
        {
            "co_code": 40294,
            "bse_code": 533573,
            "isin": "INE901L01018",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Please find attached herewith the Intimation for Investors Call scheduled to be held on 4th November 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c4c00c56-1166-454e-8d43-cfea9801c569.pdf",
            "news_date": "2025-10-27 12:13:46"
        },
        {
            "co_code": 40294,
            "bse_code": 533573,
            "isin": "INE901L01018",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Considering Unaudited Financial Results For The Quarter And Half Year Ended 30Th September 2025",
            "news_body": "Alembic Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/11/2025 inter alia to consider and approve With reference to the captioned matter the exchange is hereby informed that a Meeting of Board of Directors of the Company will be held on Tuesday 4th November 2025 inter-alia to consider and approve Unaudited Financial Results of the Company for the quarter and half year ended 30th September 2025.\r\n",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=77c788d7-76a9-451b-9b9f-de89c0d790d7.pdf",
            "news_date": "2025-10-23 12:30:19"
        },
        {
            "co_code": 40294,
            "bse_code": 533573,
            "isin": "INE901L01018",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Alembic Pharmaceuticals Limited receives USFDA Final Approval for Triamcinolone Acentonide Injectable Suspension USP 40 mg/mL (Single - Dose and Multiple - Dose Vials)",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=63464216-85f1-4720-b8d5-a1a6faebc709.pdf",
            "news_date": "2025-10-18 18:02:19"
        },
        {
            "co_code": 40294,
            "bse_code": 533573,
            "isin": "INE901L01018",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Please find attached Newspaper Publication for Special Window for re-lodgement of transfer of physical shares.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4098f7fc-d7ed-4293-ac5a-3e6186de1e25.pdf",
            "news_date": "2025-10-15 17:09:52"
        },
        {
            "co_code": 40294,
            "bse_code": 533573,
            "isin": "INE901L01018",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Please find attached herewith intimation regarding copy of newspaper advertisement related to notice for claiming shares from Companys Unclaimed Suspense Account.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b07a3ed3-09ef-43d5-bff9-02890361e296.pdf",
            "news_date": "2025-10-07 16:03:03"
        },
        {
            "co_code": 40294,
            "bse_code": 533573,
            "isin": "INE901L01018",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Please find attached herewith the Certificate under 74(5) of SEBI (DP)Regulations 2018 for the quarter ended 30th September 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e607b69c-c52a-4276-b81d-f8bcfacc2ebf.pdf",
            "news_date": "2025-10-06 18:07:37"
        },
        {
            "co_code": 40294,
            "bse_code": 533573,
            "isin": "INE901L01018",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation For Change Of Email Address Of The Registrar And Share Transfer Agent (RTA) Of The Company",
            "news_body": "We have been informed by our RTA that they have introduced a new generic email ID w.e.f. 1st October 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ddfbcd3a-c211-4b14-b729-06f30bb96fed.pdf",
            "news_date": "2025-10-01 09:55:45"
        },
        {
            "co_code": 40294,
            "bse_code": 533573,
            "isin": "INE901L01018",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Please find enclosed herewith newspaper publication of Saksham Niveshak",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=856e3fde-6250-47a6-b103-a8e4e5b420f3.pdf",
            "news_date": "2025-09-30 18:53:10"
        },
        {
            "co_code": 40294,
            "bse_code": 533573,
            "isin": "INE901L01018",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Intimation of closure of trading window",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=afdddcf2-e1e7-4195-bb65-7d5368337019.pdf",
            "news_date": "2025-09-26 17:30:06"
        },
        {
            "co_code": 40294,
            "bse_code": 533573,
            "isin": "INE901L01018",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "The Company has received USFDA Final approval for Paroxetine Extended- Release Tablets USP 25 mg and 37.5 mg.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=11b097ee-635e-4485-9db3-aaa6eeea8a25.pdf",
            "news_date": "2025-09-25 12:37:14"
        },
        {
            "co_code": 40294,
            "bse_code": 533573,
            "isin": "INE901L01018",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Please find attached herewith a copy of advertisement related to notice of loss of equity share certificate published by Company in newspaper.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=52fb7339-cfa3-44d5-85c3-6f0019255499.pdf",
            "news_date": "2025-09-15 19:04:18"
        },
        {
            "co_code": 40294,
            "bse_code": 533573,
            "isin": "INE901L01018",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Alembic Pharmaceuticals Limited Receives Establishment Inspection Report (EIR) For Its API - I & API - II Facility Located At Panelav.",
            "news_body": "Please find attached the update.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f431c6fa-89e8-4921-97ab-2082b33c1168.pdf",
            "news_date": "2025-09-13 15:52:09"
        },
        {
            "co_code": 40294,
            "bse_code": 533573,
            "isin": "INE901L01018",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Alembic Pharmaceuticals Limited receives USFDA Final Approval for Phytonadione Injectable Emulsion USP 1 mg/0.5 mL Single Dose Prefilled Syringe",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f942bbe4-8934-46c7-a09f-85fc6df0e386.pdf",
            "news_date": "2025-09-09 10:50:20"
        },
        {
            "co_code": 40294,
            "bse_code": 533573,
            "isin": "INE901L01018",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Please find attached herewith the Intimation under Regulation 30 of SEBI LODR Regulations 2015- Analysts / Investor Meet",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0a690d92-2dbf-4d39-bf6e-f3279fe6a0f7.pdf",
            "news_date": "2025-08-29 10:49:17"
        },
        {
            "co_code": 40294,
            "bse_code": 533573,
            "isin": "INE901L01018",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Alembic Pharmaceuticals Limited receives USFDA Final Approval for Macitentan Tablets 10mg.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fdbe06f9-c3ec-472c-ad97-9b04ab8b2102.pdf",
            "news_date": "2025-08-19 11:14:05"
        },
        {
            "co_code": 40294,
            "bse_code": 533573,
            "isin": "INE901L01018",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation Of One On One Investor Meet",
            "news_body": "As attached.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f5d29873-1189-4b47-9632-b2caf844720b.pdf",
            "news_date": "2025-08-18 19:57:21"
        },
        {
            "co_code": 40294,
            "bse_code": 533573,
            "isin": "INE901L01018",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 - Analysts / Investors Meeting",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fded4ac7-ff8d-4c68-8cc2-39d5b0e95799.pdf",
            "news_date": "2025-08-18 18:12:37"
        },
        {
            "co_code": 40294,
            "bse_code": 533573,
            "isin": "INE901L01018",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Alembic Pharmaceuticals Limited announces USFDA final approval for Tretinoin Cream USP 0.025%.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2cf3acf5-3310-4be8-b9a3-c5a0806deace.pdf",
            "news_date": "2025-08-15 21:27:54"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Please find attached herewith the Transcript of Post Result Conference Call held on 5th August 2025",
            "news_id": "97df9a45-8450-4f64-915a-4c2c900342a3",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=aba494e6-578f-473d-9265-6714f15dcd32.pdf",
            "news_date": "2025-08-11 19:36:09",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 40294,
            "bse_code": 533573,
            "isin": "INE901L01018",
            "ann_type": "General_Announcements",
            "descriptor": "Earnings Call Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Please find attached herewith the Transcript of Post Result Conference Call held on 5th August 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=aba494e6-578f-473d-9265-6714f15dcd32.pdf",
            "news_date": "2025-08-11 19:36:09"
        },
        {
            "co_code": 40294,
            "bse_code": 533573,
            "isin": "INE901L01018",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper Publications of Unaudited Financials Results",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2c3410ab-00fe-4135-bac4-209c8f36eeea.pdf",
            "news_date": "2025-08-06 17:33:05"
        },
        {
            "co_code": 40294,
            "bse_code": 533573,
            "isin": "INE901L01018",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 (\"SEBI Listing Regulations 2015\") - Appointment Of Statutory Auditors And Secretarial Auditors",
            "news_body": "Please find attached the intimation for appointment of Secretarial Auditors.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dcef594e-799f-42b4-a11e-bde8b2efde4e.pdf",
            "news_date": "2025-08-05 23:17:35"
        },
        {
            "co_code": 40294,
            "bse_code": 533573,
            "isin": "INE901L01018",
            "ann_type": "General_Announcements",
            "descriptor": "Appointment of Statutory Auditor/s",
            "caption": "Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s",
            "news_body": "Please find attached the intimation for appointment of Statutory Auditor",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fb154741-cbbb-450b-89ab-8a4069ef6bfa.pdf",
            "news_date": "2025-08-05 23:14:46"
        },
        {
            "co_code": 40294,
            "bse_code": 533573,
            "isin": "INE901L01018",
            "ann_type": "Outcome",
            "descriptor": "AGM",
            "caption": "Shareholder Meeting / Postal Ballot-Scrutinizers Report",
            "news_body": "Please find attached the Scrutinizers Report and Voting Result of the AGM",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b2ce65b2-fad4-4672-9dbc-5d5748fe61ab.pdf",
            "news_date": "2025-08-05 23:01:58"
        },
        {
            "co_code": 40294,
            "bse_code": 533573,
            "isin": "INE901L01018",
            "ann_type": "Outcome",
            "descriptor": "AGM",
            "caption": "Shareholder Meeting / Postal Ballot-Outcome of AGM",
            "news_body": "Please find attached the proceedings of AGM.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1ba200ee-c1d1-4fa6-9e30-a4379105ae54.pdf",
            "news_date": "2025-08-05 22:58:09"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Submission of Audio Recording of Post Results Conference Call held on 5th August 2025",
            "news_id": "282faefb-805d-46ee-8335-8bd5ce6a8e23",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9fbf5cc2-c97c-4231-ae49-d56e6960a0cd.pdf",
            "news_date": "2025-08-05 20:45:42",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 40294,
            "bse_code": 533573,
            "isin": "INE901L01018",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Submission of Audio Recording of Post Results Conference Call held on 5th August 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9fbf5cc2-c97c-4231-ae49-d56e6960a0cd.pdf",
            "news_date": "2025-08-05 20:45:42"
        },
        {
            "co_code": 40294,
            "bse_code": 533573,
            "isin": "INE901L01018",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Updated Contact Details Of Key Managerial Personnel / Senior Officials Pursuant To Regulation 30(5) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015",
            "news_body": "Please find the updated Contact details of KMP and senior officials  pursuant to Reg 30 (5) of SEBI LODR Regulations 2015.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b0f35ebc-3baa-4ed0-9c23-0705812a26a0.pdf",
            "news_date": "2025-08-05 13:26:07"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Qtr Ended 30Th June 2025.",
            "news_body": "Please find the unaudited financial Results for the quarter ended results 30th June 2025.",
            "news_id": "058f6600-24fa-47b5-a20b-b0f81f11b07c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cefcecec-aceb-453e-85f8-e1b83fd2b5de.pdf",
            "news_date": "2025-08-05 13:21:11",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 40294,
            "bse_code": 533573,
            "isin": "INE901L01018",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Unaudited Financial Results For The Qtr Ended 30Th June 2025.",
            "news_body": "Please find the unaudited financial Results for the quarter ended results 30th June 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cefcecec-aceb-453e-85f8-e1b83fd2b5de.pdf",
            "news_date": "2025-08-05 13:21:11"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find attached the investor presentation",
            "news_id": "c7f50ef2-19ed-4d2b-8211-a43615ee8bc9",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=83d227fb-47b0-46f6-8347-601c06bb1b4c.pdf",
            "news_date": "2025-08-05 13:11:10",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 40294,
            "bse_code": 533573,
            "isin": "INE901L01018",
            "ann_type": "General_Announcements",
            "descriptor": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find attached the investor presentation",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=83d227fb-47b0-46f6-8347-601c06bb1b4c.pdf",
            "news_date": "2025-08-05 13:11:10"
        },
        {
            "co_code": 40294,
            "bse_code": 533573,
            "isin": "INE901L01018",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Please find attached the Press Release.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c86d66bd-edfa-43bc-9322-c617e94d9609.pdf",
            "news_date": "2025-08-05 13:08:46"
        },
        {
            "co_code": 40294,
            "bse_code": 533573,
            "isin": "INE901L01018",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting",
            "news_body": "Please find enclosed the Outcome of Board meeting",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f23f6e78-ac63-4572-b6b2-77fe9f50dca9.pdf",
            "news_date": "2025-08-05 13:05:40"
        },
        {
            "co_code": 40294,
            "bse_code": 533573,
            "isin": "INE901L01018",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Management",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
            "news_body": "Intimation under Regulation 30 of SEBI LODR Regulations 2015 - Change in Management",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c7bd41a3-9365-4214-b778-37fe1f6eb142.pdf",
            "news_date": "2025-07-31 18:06:08"
        },
        {
            "co_code": 40294,
            "bse_code": 533573,
            "isin": "INE901L01018",
            "ann_type": "General_Announcements",
            "descriptor": "Credit Rating",
            "caption": "Announcement under Regulation 30 (LODR)-Credit Rating",
            "news_body": "Please find attached herewith the Reaffirmation of Credit Rating on Bank Loan facilities with Enhanced Limits",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=382c7fdf-7ce5-4776-ac77-9e4515b5f53f.pdf",
            "news_date": "2025-07-26 13:57:06"
        },
        {
            "co_code": 40294,
            "bse_code": 533573,
            "isin": "INE901L01018",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Alembic Pharmaceuticals receives USFDA Final approval for Carbamazepine Extended-Release Tablets USP 100 mg 200 mg and 400 mg",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3fcc8536-5cb7-4b32-8b2b-64938a512a7c.pdf",
            "news_date": "2025-07-26 11:38:02"
        },
        {
            "co_code": 40294,
            "bse_code": 533573,
            "isin": "INE901L01018",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Schedule of Post Results Conference Call",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d15f2a07-00f1-470a-a399-52ea73ded4c1.pdf",
            "news_date": "2025-07-21 20:32:11"
        },
        {
            "co_code": 40294,
            "bse_code": 533573,
            "isin": "INE901L01018",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Management",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
            "news_body": "Appointment of Senior Managerial Personnel",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=30a1c6d3-60fb-415b-91ad-5a84ea4fbda2.pdf",
            "news_date": "2025-07-21 11:49:39"
        },
        {
            "co_code": 40294,
            "bse_code": 533573,
            "isin": "INE901L01018",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Board Meeting To Consider Unaudited Financial Results For The Quarter Ended 30Th June 2025",
            "news_body": "Alembic Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/08/2025 inter alia to consider and approve Unaudited Financial Results of the Company for the quarter ended 30th June 2025.\r\n",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e9b7becb-9241-456c-9090-295260e092f6.pdf",
            "news_date": "2025-07-21 11:31:54"
        },
        {
            "co_code": 40294,
            "bse_code": 533573,
            "isin": "INE901L01018",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Management",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
            "news_body": "Please find attached herewith the intimation under Regulation 30 of SEBO LODR for Change in Management",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e47af2d1-8ef1-479e-95f4-830d4bb33ea7.pdf",
            "news_date": "2025-07-08 17:20:36"
        },
        {
            "co_code": 40294,
            "bse_code": 533573,
            "isin": "INE901L01018",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Please find attached herewith the Certificate under Reguation74(5) of the SEBI (Depositories and Participants) Regulations 2018 for the quarter ended 30th June 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4ba6111f-fb46-4f02-9f72-6b39bf037790.pdf",
            "news_date": "2025-07-07 19:00:06"
        },
        {
            "co_code": 40294,
            "bse_code": 533573,
            "isin": "INE901L01018",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Management",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
            "news_body": "Please find attached herewith the Intimation for Appointment of Chief Financial Officer of the Company",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6582423e-2c8a-4708-afd2-45fc3b3517f8.pdf",
            "news_date": "2025-07-07 14:31:05"
        },
        {
            "co_code": 40294,
            "bse_code": 533573,
            "isin": "INE901L01018",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Management",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
            "news_body": "Please find attached herewith Intimation for relinquishing the position of Chief Financial Officer of the Company",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d6ca2f97-8253-467e-8a7d-18e2dc511a29.pdf",
            "news_date": "2025-07-07 14:17:45"
        },
        {
            "co_code": 40294,
            "bse_code": 533573,
            "isin": "INE901L01018",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015",
            "news_body": "Please find enclosed herewith the Letter sent to Shareholders",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=85241e78-c90c-41ca-909b-7606c0aaf813.pdf",
            "news_date": "2025-07-04 19:08:18"
        },
        {
            "co_code": 40294,
            "bse_code": 533573,
            "isin": "INE901L01018",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015",
            "news_body": "We would like to inform that the Company has received a Demand Note from Office of the Assistant Commissioner of CGST Gangtok Sikkim.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b26acfcb-25d6-4ba8-9b60-afb309039e67.pdf",
            "news_date": "2025-07-03 15:36:07"
        },
        {
            "co_code": 40294,
            "bse_code": 533573,
            "isin": "INE901L01018",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015",
            "news_body": "Alembic Pharmaceuticals Inc. wholly owned subsidiary of Alembic Pharmaceuticals Limited has acquired Utility Therapeutics Ltd.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d6984f68-7185-453f-8fd3-6fcbbe57d87e.pdf",
            "news_date": "2025-07-03 08:48:05"
        },
        {
            "co_code": 40294,
            "bse_code": 533573,
            "isin": "INE901L01018",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Please find attached herewith a copy of advertisement related to notice of loss of equity share certificate.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b20ebbb3-70f6-423f-aab9-4da997ab8e50.pdf",
            "news_date": "2025-07-02 17:53:22"
        },
        {
            "co_code": 40294,
            "bse_code": 533573,
            "isin": "INE901L01018",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Volume Movement",
            "news_body": "Please find our response for the volume movement.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e1eacfc7-6cb4-4a64-9191-ab282664fdf1.pdf",
            "news_date": "2025-07-01 13:15:17"
        },
        {
            "co_code": 40294,
            "bse_code": 533573,
            "isin": "INE901L01018",
            "ann_type": "General",
            "descriptor": "Clarification",
            "caption": "Clarification sought from Alembic Pharmaceuticals Ltd",
            "news_body": "The Exchange has sought clarification from Alembic Pharmaceuticals Ltd on July 01 2025 with reference to Movement in Volume. <BR><BR>The reply is awaited.",
            "file_url": "",
            "news_date": "2025-07-01 12:07:34"
        },
        {
            "co_code": 40294,
            "bse_code": 533573,
            "isin": "INE901L01018",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Alembic Pharmaceuticals Receives USFDA Final Approval For Doxorubicin Hydrochloride Liposome Injection",
            "news_body": "Please find enclosed the USFDA Approval received for Doxorubicin Hydrochloride Liposome Injection",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4536e534-0fe4-4815-a7f8-7c49f045c087.pdf",
            "news_date": "2025-06-29 08:57:01"
        },
        {
            "co_code": 40294,
            "bse_code": 533573,
            "isin": "INE901L01018",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Intimation of Closure of Trading Window",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=33e19d2d-b4bc-4b2b-badb-60806738e853.pdf",
            "news_date": "2025-06-26 17:31:36"
        },
        {
            "co_code": 40294,
            "bse_code": 533573,
            "isin": "INE901L01018",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Management",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
            "news_body": "Resignation of Senior Managerial Personnel",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5152054e-a603-46b6-a0c9-500286c01fb8.pdf",
            "news_date": "2025-06-25 13:47:27"
        },
        {
            "co_code": 40294,
            "bse_code": 533573,
            "isin": "INE901L01018",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Alembic Pharmaceuticals Limited Has Received Establishment Inspection Report (EIR) For Its API-III Facility At Karakhadi",
            "news_body": "The exchange is hereby informed that the Company has received an Establishment Inspection Report from USFDA for inspection carried out at API- III Facility at Karakhadi.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=138ed7dc-05f5-433f-84fa-9bda60c89028.pdf",
            "news_date": "2025-06-18 12:07:38"
        },
        {
            "co_code": 40294,
            "bse_code": 533573,
            "isin": "INE901L01018",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 - Analysts / Investors Meeting",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5778105b-363b-4962-b52c-06b99d80e9f1.pdf",
            "news_date": "2025-06-18 11:55:45"
        },
        {
            "co_code": 40294,
            "bse_code": 533573,
            "isin": "INE901L01018",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.",
            "news_body": "The Company has issued a corporate guarantee in favour of JP Morgan Chase Bank N.A. for getting term loan facility in Alembic Pharmaceuticals Inc. USA.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e4cc4f57-09e6-43bb-b89d-b2089c472971.pdf",
            "news_date": "2025-06-17 19:10:13"
        },
        {
            "co_code": 40294,
            "bse_code": 533573,
            "isin": "INE901L01018",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Please find attached herewith the Newspaper Publication published on 17th June 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b888c31b-224f-4c83-b192-1113786e6a4b.pdf",
            "news_date": "2025-06-17 17:43:13"
        },
        {
            "co_code": 40294,
            "bse_code": 533573,
            "isin": "INE901L01018",
            "ann_type": "General_Announcements",
            "descriptor": "Business Responsibility and Sustainability Reporting (BRSR)",
            "caption": "Business Responsibility and Sustainability Reporting (BRSR)",
            "news_body": "We enclose herewith the BRSR of the Company for the financial year ended 31st March 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3c1dbd6b-4b63-45dc-9095-319022c72930.pdf",
            "news_date": "2025-06-16 11:26:05"
        },
        {
            "co_code": 40294,
            "bse_code": 533573,
            "isin": "INE901L01018",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Submission Of Notice Of The 15Th Annual General Meeting Of The Company",
            "news_body": "Pursuant to regulation 30 of SEBI LODR 2015 Please find enclosed herewith the 15th Notice of Annual General meeting of the Company scheduled to be held on 5th August 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e32de9e8-2bac-478b-9e12-d5ce0bcfa8c3.pdf",
            "news_date": "2025-06-16 11:21:12"
        },
        {
            "co_code": 40294,
            "bse_code": 533573,
            "isin": "INE901L01018",
            "ann_type": "Intimation",
            "descriptor": "AGM",
            "caption": "Submission Of Notice Of The 15Th Annual General Meeting Of The Company",
            "news_body": "We enclose herewith the notice of 15th Annual General Meeting of the Company scheduled to be held on 5th August 2025 at 3:00 PM through Video Conferencing or Other Audio Video Means.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9a93be3d-8628-4a8b-9073-3ebc9ff4f002.pdf",
            "news_date": "2025-06-16 11:17:00"
        },
        {
            "co_code": 40294,
            "bse_code": 533573,
            "isin": "INE901L01018",
            "ann_type": "General_Announcements",
            "descriptor": "Reg. 34 (1) Annual Report",
            "caption": "Reg. 34 (1) Annual Report.",
            "news_body": "Please find the Annual Report for the financial year ended 31st March 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9b7dbde0-239f-4413-80ca-fce12a1dc9aa.pdf",
            "news_date": "2025-06-16 11:10:04"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Please find attached the transcript of the post results conference call.",
            "news_id": "b8b2d1c2-0e49-485f-9ae0-c02febab85ff",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0aef0e86-5752-47d8-92db-937dfd500357.pdf",
            "news_date": "2025-05-12 19:11:44",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Submission of Audio Recording of Post Results Conference Call held on 6th May 2025",
            "news_id": "696017a4-cd9d-4f5c-97de-d7312af0a13d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=80ac3eb5-e214-4a21-919f-33239b2a419c.pdf",
            "news_date": "2025-05-06 19:12:12",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter And Financial Year Ended 31St March 2025",
            "news_body": "Please find attached herewith the Financial Results for the quarter and Financial Year ended 31st March 2025",
            "news_id": "8bbc459f-10fa-44c7-8690-0cf7bf3953ef",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=da588a9e-d79f-4c45-aca0-a50e01bd1602.pdf",
            "news_date": "2025-05-06 14:10:20",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find attached herewith the Investor Presentation.",
            "news_id": "5dde75af-10d8-4a57-97b6-487d669c5b0d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fc5456a4-8aaa-4a0b-b1b4-79046750b3f1.pdf",
            "news_date": "2025-05-06 14:00:03",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Please Find Attached Herewith The Outcome Of Board Meeting",
            "news_body": "Outcome of Board Meeting",
            "news_id": "c193e1f2-c25b-4155-990b-b92a3425d528",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=570a7297-1b32-45b9-83fe-1405171a664f.pdf",
            "news_date": "2025-05-06 13:53:33",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find attached the Investor Presentation.",
            "news_id": "9b689706-6182-4cc6-8ac7-d2126f00cb93",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=404caac6-1986-45e2-a318-fb6c9d5e9db2.pdf",
            "news_date": "2025-02-03 14:42:48",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results For The Quarter And Nine Months Ended 31St December 2024",
            "news_body": "Results for the quarter and nine months ended 31st December 2024",
            "news_id": "7336af47-9cd6-4084-b516-aee8a900d8a6",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c8bea75b-3c20-44cf-87d8-ca9409741f82.pdf",
            "news_date": "2025-02-03 14:37:30",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of the Earnings Call held on 7th November, 2024",
            "news_id": "29261bd8-31b2-4c3b-a732-fc63dd58b94c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3a0765f9-861d-4c5a-8f07-9523c029f51f.pdf",
            "news_date": "2024-11-12 15:31:18",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Please find enclosed herewith the Audio Recording of Post Results Conference Call held on 7th November, 2024",
            "news_id": "cee4ed13-3930-4f92-8b62-ac80e0f4dda7",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=56cbabbf-4b4b-4d37-82fc-29b6e36ed6c8.pdf",
            "news_date": "2024-11-07 18:26:45",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find attached herewith the Investor Presentation on the Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2024.",
            "news_id": "314dab5a-de73-4673-a953-0fcee38ca1bb",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=22572b54-188f-44bd-a37e-45868dabc316.pdf",
            "news_date": "2024-11-07 13:19:09",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter And Half Year  Ended September, 2024",
            "news_body": "The exchange is hereby informed  that the Board of Directors at their meeting held today has approved the Unaudited Financial Results for the quarter and half year ended September, 2024",
            "news_id": "3cf806a2-7d8d-4d57-8ffa-9e22bdeb7360",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b085f3ba-bd00-4c4d-a466-d4d16009f3bd.pdf",
            "news_date": "2024-11-07 13:06:20",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement Under Regulation 30 (LODR) - Earnings Call Transcript",
            "news_body": "Transcript of the Earnings Call held on 8th August, 2024",
            "news_id": "31f097c6-c003-4be5-8813-007e2378ca41",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c798dfcf-c04a-4179-955f-b1dba967f348.pdf",
            "news_date": "2024-08-14 15:42:13",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Please find enclosed herewith the Audio Recording of Post Results Conference Call held on 8th August, 2024",
            "news_id": "ecb0a65a-a5a1-4764-9ea2-ca96ce46ef37",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=eb8efdf2-fa79-4e0e-9c79-89fe3829a68c.pdf",
            "news_date": "2024-08-08 19:27:42",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find enclosed herewith the Investor Presentation on the Unaudited Financial Results of the Company for the quarter ended June 30, 2024. Kindly take the same in record.",
            "news_id": "93bde81a-33c0-4db3-aadd-3f38539227c0",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f5a6ce8c-3ba7-4ab7-b19c-da1c0175ccd2.pdf",
            "news_date": "2024-08-08 13:45:13",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter Ended June, 2024",
            "news_body": "The exchange is hereby informed that the Board of Directors in their Meeting held today has approved the Unaudited Financial Results for the Quarter ended June, 2024.",
            "news_id": "918db1c0-72aa-4fa0-a1ef-2e4247038fc6",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=51ba19f8-9eb7-45a0-a522-22edb3342b7c.pdf",
            "news_date": "2024-08-08 13:35:37",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcripts of the Earnings Call held on 9th May, 2024.",
            "news_id": "d37690a3-4df8-4a70-a7f2-f11c1171df0d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=38f03d7c-fbef-489e-9535-0b88440b447e.pdf",
            "news_date": "2024-05-15 19:03:13",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Please find attached the Audio Recording of the Post Results Conference call.",
            "news_id": "22c9df89-cb73-41f9-8141-35eb338706ec",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=87cd1c1a-e839-484a-b02d-2c4f6e5c95a6.pdf",
            "news_date": "2024-05-09 21:43:43",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find enclosed herewith the Investor Presentation of the Audited Financial Results of the Company for the quarter and financial year ended March 31, 2024. We request you to kindly take the same in record.",
            "news_id": "43753ad7-3532-4f15-aaa7-faec20561c04",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2757b7cf-72f7-4d5f-9279-74cd78a61d8b.pdf",
            "news_date": "2024-05-09 14:23:03",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results For The Quarter And Financial Year Ended March 31, 2024",
            "news_body": "The exchange is hereby informed that the Board of Directors of Alembic Pharmaceuticals Limited at its Meeting held today inter alia approved the Audited Financial results for the Quarter and Financial year ended March 31, 2024 and recommended dividend of Rs. 11/- (550%) per Equity Share.",
            "news_id": "529f2064-e79c-42dc-91c3-f68b91400ea9",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f2b89164-67a3-46c3-9fc5-cda72189d4c3.pdf",
            "news_date": "2024-05-09 14:17:15",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of the Earnings Call held on 5th February, 2024",
            "news_id": "d791aa55-dd8e-4ce5-96aa-5793ea8db2e7",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=17b6d93c-a135-4678-a5f9-8c6003e45819.pdf",
            "news_date": "2024-02-09 17:56:12",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "With reference to the captioned subject, this is to inform the exchange that the audio recording has been hosted on the website of the Company and can be accessed at https://alembicpharmaceuticals.com/quarterly-results/",
            "news_id": "960ed5e7-ebbe-4cea-8b9e-16383c7de564",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=52531677-8b20-47ec-aca6-d7e241a66dc9.pdf",
            "news_date": "2024-02-05 19:59:14",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find attached herewith the Investor Presentation",
            "news_id": "57e1d5ca-e4b3-422d-af8e-2e8bc388d7bd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2d7b4bc1-ec33-4a51-b73e-0fee5ef0326e.pdf",
            "news_date": "2024-02-05 14:23:10",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Standalone And Consolidated Financial Results For The Quarter And Half Year Ended 31St December, 2023",
            "news_body": "Please find attached herewith the Unaudited Financial results for the quarter and half year ended 31st December, 2023",
            "news_id": "0cce015e-762b-4ece-a1e7-6827b23f6595",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0a8b90e0-22b2-42b8-ae90-35ed8bd8de96.pdf",
            "news_date": "2024-02-05 14:17:14",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Please find attached schedule of Post Results Conference Call",
            "news_id": "ef8c36d9-00f7-4f9f-9bb7-6b59d677c496",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a5e6a1ae-0c71-4313-9dc5-4575a372e619.pdf",
            "news_date": "2024-01-18 19:31:11",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Please find attached the audio recording.",
            "news_id": "e87dd306-ed11-40b3-a303-dee190600900",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=63c3856b-64a9-4196-9e99-ce802dfaded1.pdf",
            "news_date": "2023-11-07 19:13:44",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "PLease find attached the investor presentation",
            "news_id": "6a3e27ac-a112-4c7d-9ec6-40eb329dfdeb",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0c84ed0d-b30b-459a-bc50-fad68e99cfb5.pdf",
            "news_date": "2023-11-07 13:47:27",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results 30Th September, 2023",
            "news_body": "PLease find attached the Results",
            "news_id": "f54635f5-b76e-4958-b075-ce6c1b329608",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c9e50549-3f73-4de6-b5b6-a3f98b03eae0.pdf",
            "news_date": "2023-11-07 13:43:04",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Please find enclosed herewith the Transcript of the Conference call held on 4th August, 2023.",
            "news_id": "2c6da3c8-e1f8-4ba5-a716-8ec2a6e520a6",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f6c94a76-02f2-405b-ad92-85becb5a6404.pdf",
            "news_date": "2023-08-09 18:55:46",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "With reference to the captioned subject, this is to inform the exchange that the audio recording has been hosted on the website of the Company",
            "news_id": "19007a01-d24f-481c-b5fa-4a23cb5a915e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8b9a2e4b-4ca0-4a0f-b213-a9604a22bb25.pdf",
            "news_date": "2023-08-04 20:44:16",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find attached the Investor Presentation for the quarter ended 30th June, 2023",
            "news_id": "251fd446-22c9-4a43-ada1-3326f35b0e19",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a1b264b5-0c02-478f-9be4-bdb2fa40e3e3.pdf",
            "news_date": "2023-08-04 13:41:49",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter Ended 30.06.2023",
            "news_body": "Please find enclosed the Unaudited Financial Results for the qtr ended 30th June, 2023",
            "news_id": "96efb62d-6300-4910-8ea6-9a63711d83f1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6684c470-f7ba-48d1-a426-121fa376558f.pdf",
            "news_date": "2023-08-04 13:38:34",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "With reference to the captioned matter, please find enclosed herewith the transcript of the Conference Call held on 5th May, 2023.",
            "news_id": "842a5b9f-bf35-4ed7-adb9-b38778240228",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7b765bfe-2685-4055-9795-d33d278ed20b.pdf",
            "news_date": "2023-05-12 18:34:38",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "With reference to the captioned matter, this is to inform the exchange that the audio recording has been hosted on the website of the Company and can be accessed at https://alembicpharmaceuticals.com/quarterly-results/",
            "news_id": "486f4279-1808-48cf-abf8-efc6b20fd339",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1bfb75a4-542f-4801-a85b-8cf9d625f897.pdf",
            "news_date": "2023-05-06 11:32:58",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find enclosed the Investors Presentation on the Audited Financial Results of the Company for the quarter and financial year ended 31st March, 2023.We request you to kindly take the same on record.",
            "news_id": "2c6022d1-edc8-43fb-af91-921920b70e6e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f746eb52-e2f3-4fbf-94f8-d341cf1d1c6a.pdf",
            "news_date": "2023-05-05 17:11:10",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Financial Results",
            "news_body": "The exchange is hereby informed that the Board of Directors of Alembic Pharmaceuticals Limited at its meeting held today has inter alia Approved the Audited Financial Results for the quarter and financial year ended''31st March, 2023. and Recommended a dividend of Rs. 8/- (400%) per Equity Share.",
            "news_id": "ae4bce51-becc-421d-a812-5851eb625a71",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=35de2f20-ebec-43a8-9983-e7f29274ba3f.pdf",
            "news_date": "2023-05-05 17:02:27",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "With reference to the captioned matter, please find enclosed herewith the transcript of the Conference Call held on 1st February, 2023.We request you to kindly take the same on record.",
            "news_id": "403ab9b6-3495-42b5-975b-ec2aca17aa92",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4ecfdf48-51b5-4b6d-aa3a-a22cec3f6356.pdf",
            "news_date": "2023-02-07 19:44:03",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "With reference to the captioned matter, this is to inform the exchange that the audio recording has been hosted on the website of the Company and can be accessed at https://alembicpharmaceuticals.com/quarterly-results/ We request you to kindly take the same on record.",
            "news_id": "654a2b01-1c19-4c1c-9c19-79ae641e891b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d881a07d-5cc0-4228-a515-eb6ad2702645.pdf",
            "news_date": "2023-02-01 20:19:27",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter And Nine Months Period Ended 31St December, 2022",
            "news_body": "With reference to the captioned matter, the exchange is hereby informed that the Board of Directors of Alembic Pharmaceuticals Limited at its meeting held today has inter alia approved the Unaudited Financial Results for the quarter and nine months period ended 31st December, 2022.",
            "news_id": "a5cc3ffc-1d41-4575-b1d3-04bbca648e9d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0555b9f1-7be6-4611-a7d0-66640a3e8c56.pdf",
            "news_date": "2023-02-01 16:30:13",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting",
            "news_body": "With reference to the captioned matter, the exchange is hereby informed that the Board of Directors of Alembic Pharmaceuticals Limited at its meeting held today has inter alia approved the Unaudited Financial Results for the quarter and nine months period ended 31st December, 2022.",
            "news_id": "f81a7ff2-7e1b-4abb-941b-2e4909450216",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ace347c7-c5f1-482b-ad3e-582c9ebe2bc8.pdf",
            "news_date": "2023-02-01 16:27:05",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Of Related Party Transactions Pursuant To Regulation 23(9) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosures Requirements) Regulations, 2015",
            "news_body": "Pursuant to Regulation 23(9) of the SEBI Listing Regulations, 2015, we enclose herewith Disclosure of Related Party Transactions for the half year ended 30th September, 2022.We request you to kindly take the same on record.",
            "news_id": "3162909a-93b0-46f1-9752-fb3752d85bc9",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=389b4945-6435-41e9-aa91-3f3840a27452.pdf",
            "news_date": "2022-11-24 19:21:34",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "With reference to the captioned matter, please find enclosed herewith the transcript of the Conference Call held on 11th November, 2022.We request you to kindly take the same on record.",
            "news_id": "b91092dc-f64f-4397-91ca-b511c22e6279",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f640dfc6-50c0-495a-8a8f-5550cf2ae0b7.pdf",
            "news_date": "2022-11-17 18:44:00",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "With reference to the captioned matter, this is to inform the exchange that the audio recording has been hosted on the website of the Company and can be accessed at https://alembicpharmaceuticals.com/quarterly-results/",
            "news_id": "24f9c227-b055-46fb-8658-9d79344bdb5d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a6e5ee77-f777-4f5c-bd10-9101f2070750.pdf",
            "news_date": "2022-11-11 20:40:28",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter And Half Year Ended 30Th September, 2022",
            "news_body": "With reference to the captioned matter, the exchange is hereby informed that the Board of Directors of Alembic Pharmaceuticals Limited at its meeting held today has inter alia approved the Unaudited Financial Results for the quarter and half year ended 30th September, 2022.",
            "news_id": "d108df89-04e4-44be-b180-ff092a0f285d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e7a4b1f0-6fce-4149-9782-857a1bba2d6e.pdf",
            "news_date": "2022-11-11 13:46:50",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "With reference to the captioned matter, please find enclosed herewith the transcript of the Conference Call held on 4th August, 2022.We request you to kindly take the same on record.",
            "news_id": "6ae06a90-e759-4a6b-a76c-5d19eb1cbed2",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=eb9d1d43-e4b3-42cb-90fc-36a4002667ac.pdf",
            "news_date": "2022-08-10 11:21:09",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter Ended 30Th June, 2022.",
            "news_body": "With reference to the captioned matter, the exchange is hereby informed that the Board of Directors of Alembic Pharmaceuticals Limited at its meeting held today has inter alia approved:<BR> <BR> 1) Unaudited Financial Results for the quarter ended 30th June, 2022.<BR> 2) Re-classification of the dividend of Rs. 10/- (500%) per equity share for the financial year 2021-22, recommended by them at their meeting held on 2nd May, 2022, into interim dividend for the financial year 2021-22. <BR> <BR> Please note that the said interim dividend will be paid to those shareholders whose names appear on the Register of Members as on the Record Date fixed for the purpose i.e. Thursday, 18th August, 2022. No further final dividend for the financial year 2021-22 shall be declared.<BR> <BR> The time of commencement of the Board Meeting was 12:30 p.m. and the time of conclusion was 3:30 p.m.<BR> <BR> We request you to kindly take the same on record.<BR>",
            "news_id": "4776dbd1-a0da-4798-ba85-9934e3e40e53",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f3c9c1b4-3433-4074-a2f2-f18e90972d41.pdf",
            "news_date": "2022-08-04 17:36:01",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting",
            "news_body": "With reference to the captioned matter, the exchange is hereby informed that the Board of Directors of Alembic Pharmaceuticals Limited at its meeting held today has inter alia approved:<BR> <BR> 1) Unaudited Financial Results for the quarter ended 30th June, 2022.<BR> 2) Re-classification of the dividend of Rs. 10/- (500%) per equity share for the financial year 2021-22, recommended by them at their meeting held on 2nd May, 2022, into interim dividend for the financial year 2021-22. <BR> <BR> Please note that the said interim dividend will be paid to those shareholders whose names appear on the Register of Members as on the Record Date fixed for the purpose i.e. Thursday, 18th August, 2022. No further final dividend for the financial year 2021-22 shall be declared.<BR> <BR> The time of commencement of the Board Meeting was 12:30 p.m. and the time of conclusion was 3:30 p.m.<BR> <BR> We request you to kindly take the same on record.<BR>",
            "news_id": "7bbc2936-28c8-4647-873e-d40a487e366e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2803057c-d821-4034-aff3-e9631934d052.pdf",
            "news_date": "2022-08-04 15:46:27",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure On Related Party Transactions Pursuant To Regulation 23(9) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosures Requirements) Regulations, 2015",
            "news_body": "With reference to the captioned matter, we would like to inform that pending the release of XBRL template in the new format prescribed by SEBI vide its Circular dated 22nd November, 2021 on Disclosure obligations of listed entities in relation to Related Party Transactions and based on the verbal guidance provided by the stock exchanges, we enclose herewith scanned copy of disclosures on Related Party Transactions for the half year ended 31st March, 2022. We will upload the said disclosures in XBRL as and when the template is released by the stock exchanges.We request you to kindly take the same on record.",
            "news_id": "d3af5ae7-0e35-40b6-9a69-40026b0b1b7d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cd7f1a95-12d1-4133-a4e1-ea312ad9b653.pdf",
            "news_date": "2022-05-16 19:54:01",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "With reference to the captioned matter, please find enclosed herewith the transcript of the Conference Call held on 2nd May, 2022.We request you to kindly take the same on record.",
            "news_id": "3c178b00-9934-49c8-9675-2622d9e25c98",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=56abeb04-b7f4-4450-a7a7-9f1b14c98826.pdf",
            "news_date": "2022-05-09 16:36:40",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "With reference to the captioned matter, this is to inform the exchange that the audio recording has been hosted on the website of the Company and can be accessed at https://alembicpharmaceuticals.com/quarterly-results/ We request you to kindly take the same on record.",
            "news_id": "0245bb5e-a5d2-43cf-ad86-072ac2f4231b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=69c6dea9-d878-49a0-998e-18eb95930525.pdf",
            "news_date": "2022-05-03 13:44:43",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results For The Quarter And Financial Year Ended 31St March, 2022.",
            "news_body": "With reference to the captioned matter, the exchange is hereby informed that the Board of Directors of Alembic Pharmaceuticals Limited at its meeting held today has inter alia approved:<BR> <BR> 1) Audited Financial Results for the quarter and financial year ended 31st March, 2022.<BR> <BR> 2) Recommended a dividend of Rs. 10/- (500%) per Equity Share having face value of Rs. 2/- each, subject to approval of the Shareholders at the ensuing Annual General Meeting.<BR> <BR> The time of commencement of the Board Meeting was 2:00 p.m. and the time of conclusion was 3:35 p.m.<BR> <BR> We request you to kindly take the same on record.<BR>",
            "news_id": "7baf5de7-5a39-4774-babe-5908b9759bd1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5c02a743-ab1a-4024-995b-07e217dd9185.pdf",
            "news_date": "2022-05-02 16:09:33",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting",
            "news_body": "With reference to the captioned matter, the exchange is hereby informed that the Board of Directors of Alembic Pharmaceuticals Limited at its meeting held today has inter alia approved:<BR> <BR> 1) Audited Financial Results for the quarter and financial year ended 31st March, 2022.<BR> <BR> 2) Recommended a dividend of Rs. 10/- (500%) per Equity Share having face value of Rs. 2/- each, subject to approval of the Shareholders at the ensuing Annual General Meeting.<BR> <BR> The time of commencement of the Board Meeting was 2:00 p.m. and the time of conclusion was 3:35 p.m.<BR> <BR> We request you to kindly take the same on record.",
            "news_id": "56316cae-f729-40d8-8203-9b3ef493958f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=94eb5db6-9dd4-4c0e-8dc4-e1389a545057.pdf",
            "news_date": "2022-05-02 15:58:57",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "With reference to our intimation dated 28th January, 2022 regarding schedule of Post Results Conference Call, please find enclosed herewith the transcript of the said Conference Call held on 10th February, 2022.We request you to kindly take the same on record.",
            "news_id": "7a25ee62-4287-48b4-b168-96e6e1884841",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=13378744-332d-4471-92b2-c65752f90d88.pdf",
            "news_date": "2022-02-16 19:21:47",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter And Nine Months Period Ended 31St December, 2021.",
            "news_body": "Unaudited Financial Results for the quarter and nine months period ended 31st December, 2021.<BR> <BR> Please find enclosed herewith standalone and consolidated financial results of the Company for the quarter and nine months period ended 31st December, 2021, Press Release and Investor Presentation.",
            "news_id": "860b819d-8ef3-40d8-95cd-a3ac90795dd5",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=be13d151-46d6-47a8-a4f7-d9408becf46a.pdf",
            "news_date": "2022-02-10 14:19:09",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting",
            "news_body": "With reference to the captioned matter, the exchange is hereby informed that the Board of Directors of Alembic Pharmaceuticals Limited at its meeting held today has inter alia approved the:   <BR> <BR> 1. Unaudited Financial Results for the quarter and nine months period ended 31st December, 2021.<BR> 2. Appointment of Mr. Ashok Barat (DIN: 00492930) as an Independent Director of the Company w.e.f. 10th February, 2022. The detailed disclosures is being submitted vide a separate communication.<BR> <BR> Please find enclosed herewith standalone and consolidated financial results of the Company for the quarter and nine months period ended 31st December, 2021, Press Release and Investor Presentation.<BR> <BR> The time of commencement of the Board Meeting was 12:30 p.m. and the time of conclusion was 2:00 p.m.<BR> <BR> We request you to kindly take the same on record.<BR>",
            "news_id": "ba11f7c3-7a39-4c07-84c5-0ec4cb9cbb26",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d993dfb2-bb32-4355-a1e6-4697a8ff778e.pdf",
            "news_date": "2022-02-10 14:14:26",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "With reference to our intimation dated 29th October, 2021 regarding schedule of Post Results Conference Call, please find enclosed herewith the transcript of the said Conference Call held on 10th November, 2021.<BR> <BR> We request you to kindly take the same on record.<BR>",
            "news_id": "e73b9d58-2a62-4739-9ac9-c80020cea9cc",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f7d95702-c637-438a-a766-15dacf17da92.pdf",
            "news_date": "2021-11-19 19:09:00",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter And Half Year Ended 30Th September, 2021",
            "news_body": "With reference to the captioned matter, the exchange is hereby informed that the Board of Directors of Alembic Pharmaceuticals Limited at its meeting held today has approved the Unaudited Financial Results for the quarter and half year ended 30th September, 2021.<BR> <BR> The time of commencement of the Board Meeting was 12:20 p.m. and the time of conclusion was 1:45 p.m.<BR> <BR> We request you to kindly take the same on record.<BR>",
            "news_id": "5e075f58-a47a-4f70-8d53-ae0677378e42",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=57b46bb6-6c54-4fa5-8e5d-2bc629ade888.pdf",
            "news_date": "2021-11-10 14:02:30",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting",
            "news_body": "With reference to the captioned matter, the exchange is hereby informed that the Board of Directors of Alembic Pharmaceuticals Limited at its meeting held today has approved the Unaudited Financial Results for the quarter and half year ended 30th September, 2021.<BR> <BR> The time of commencement of the Board Meeting was 12:20 p.m. and the time of conclusion was 1:45 p.m.<BR> <BR> We request you to kindly take the same on record.",
            "news_id": "d10d8d65-3a00-444f-89bc-7e69b7325c23",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d46a4c44-0644-44d2-938d-bcc4692b370d.pdf",
            "news_date": "2021-11-10 13:57:24",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "With reference to our intimation dated 15th July, 2021 regarding schedule of Post Results Conference Call, please find enclosed herewith the transcript of the said Conference Call held on 26th July, 2021.<BR> <BR> We request you to kindly take the same on record.<BR>",
            "news_id": "28ce6c9e-070f-40ec-8e8d-fc81c369f25a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dc1e1156-1b64-4222-ba63-4108c6b11512.pdf",
            "news_date": "2021-08-02 13:22:04",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter Ended 30Th June, 2021",
            "news_body": "With reference to the captioned matter, the exchange is hereby informed that the Board of Directors of Alembic Pharmaceuticals Limited at its meeting held today has approved the Unaudited Financial Results for the quarter ended 30th June, 2021.<BR> <BR> We enclose herewith the following: <BR> a)  Consolidated Unaudited Financial Results for the quarter ended 30th June, 2021.<BR> b) Standalone Unaudited Financial Results for the quarter ended 30th June, 2021. <BR> c) Limited Review Report by Statutory Auditors on Consolidated as well as on Standalone Unaudited Financial Results.<BR> d) Press Release.<BR> e) Investor Presentation.<BR> <BR> The time of commencement of the Board Meeting was 1:30 p.m. and the time of conclusion was 2:50 p.m.<BR> <BR> We request you to kindly take the same on record.<BR>",
            "news_id": "484084ee-a97b-4ac1-b72d-fe3b489c0c84",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=842666cb-d535-445f-9bad-e6f00d5b8696.pdf",
            "news_date": "2021-07-26 15:08:40",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting",
            "news_body": "With reference to the captioned matter, the exchange is hereby informed that the Board of Directors of Alembic Pharmaceuticals Limited at its meeting held today has approved the Unaudited Financial Results for the quarter ended 30th June, 2021.<BR> <BR> We enclose herewith the following: <BR> a)  Consolidated Unaudited Financial Results for the quarter ended 30th June, 2021.<BR> b) Standalone Unaudited Financial Results for the quarter ended 30th June, 2021. <BR> c) Limited Review Report by Statutory Auditors on Consolidated as well as on Standalone Unaudited Financial Results.<BR> d) Press Release.<BR> e) Investor Presentation.<BR> <BR> The time of commencement of the Board Meeting was 1:30 p.m. and the time of conclusion was 2:50 p.m.<BR> <BR> We request you to kindly take the same on record.<BR>",
            "news_id": "ec451a49-4869-4d86-bc79-afdbba937322",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e8953cd4-8b09-4c89-b114-822833bca8ae.pdf",
            "news_date": "2021-07-26 15:05:30",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Of Related Party Transactions For The Half Year Ended 31St March, 2021",
            "news_body": "Pursuant to Regulation 23(9) of the Listing Regulations, 2015, we enclose herewith Disclosure of Related Party Transactions, on a consolidated basis, for the half year ended 31st March, 2021.",
            "news_id": "953ae82a-3734-4ff9-b51b-3a9a68f6e7d5",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=49aad200-55ae-4472-af68-f3d9e5ceb0f8.pdf",
            "news_date": "2021-05-25 12:11:18",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "With reference to our intimation dated 27th April, 2021 regarding schedule of Post Results Conference Call, please find enclosed herewith the transcript of the said Conference Call held on 4th May, 2021.<BR> <BR> We request you to kindly take the same on record.<BR>",
            "news_id": "06f22de9-8f7b-409b-b73d-9c8877f7434a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=868ae8c2-ab6c-48ee-b5e9-bb31402d2498.pdf",
            "news_date": "2021-05-13 18:29:35",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results For The Quarter And Financial Year Ended 31St March, 2021",
            "news_body": "Please refer attached file with the attachments",
            "news_id": "cc900f5e-35a2-4c26-9092-2fafe94ce124",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=59a57476-b0f4-456d-a77e-168f701cc8de.pdf",
            "news_date": "2021-05-04 14:35:01",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "APLLTD",
            "disp": "Alembic Pharmaceuticals",
            "bse_code": 533573,
            "isin": "INE901L01018",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting",
            "news_body": "Please find attached herewith covering letter along with the documents.",
            "news_id": "6ac97efb-ce51-4524-98d9-74dffcb154e9",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1e7eaab6-dd0d-4b9f-a9e3-28dccb1abae2.pdf",
            "news_date": "2021-05-04 14:25:08",
            "seo": "alembic-pharmaceuticals-ltd",
            "ltp": 804.35,
            "ch": 2.4500000000000455,
            "pch": 0.30552437959845935,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 25328,
            "exch": "NSE",
            "seg": "E"
        }
    ]
}